source
- Analysts focus on three programs in big year for Bristol MyersWall Street’s expectations for Bristol Myers Squibb’s upcoming slate of data readouts are reaching a fever pitch. Analysts lobbed questions regarding at least half a dozen trial results expected by…Endpoints · 3mo ago↗ source
- Lilly posts another ‘blowout quarter’ as focus turns to Foundayo launchA strong performance from Mounjaro overseas boosted Lilly’s results, and the company raised its guidance for the year for both profit and revenue.BioPharma Dive · 3mo ago↗ source
- XTL Bio to acquire psychedelic biotech; WuXi AppTec’s Q1 revenue risePlus, news about PCI Pharma: 🏭 XTL Bio steps into psychedelics: XTL Biopharmaceuticals is acquiring 100% of the outstanding shares of psychedelic-focused biotech Psyga Bio. XTL will gain Psyga’s m…